124 related articles for article (PubMed ID: 4106089)
1. Further studies on migration inhibitory factor (MIF): evidence for its glycoprotein nature.
Remold HG; David JR
J Immunol; 1971 Oct; 107(4):1090-8. PubMed ID: 4106089
[No Abstract] [Full Text] [Related]
2. Physicochemical characteristics of several mediators from stimulated guinea pig and human lymphocytes.
David JR; Coyne JA; Rocklin RE; Nathan CF; Remold HG
Transplant Proc; 1972 Jun; 4(2):241-2. PubMed ID: 4113698
[No Abstract] [Full Text] [Related]
3. Characterization of migration inhibitory factor (MIF) from guinea pig lymphocytes stimulated with concanavalin A.
Remold HG; David RA; David JR
J Immunol; 1972 Sep; 109(3):578-86. PubMed ID: 4115544
[No Abstract] [Full Text] [Related]
4. Mechanism of action of migration inhibitory factor (MIF). I. Evidence for a receptor for MIF present on the peritoneal macrophage but not on the alveolar macrophage.
Leu RW; Eddleston AL; Hadden JW; Good RA
J Exp Med; 1972 Sep; 136(3):589-603. PubMed ID: 4115133
[TBL] [Abstract][Full Text] [Related]
5. Studies on migration inhibitory factor (MIF): recovery of MIF activity after purification by gel filtration and disc electrophoresis.
Remold HG; Katz AB; Haber E; David JR
Cell Immunol; 1970 May; 1(1):133-45. PubMed ID: 4108779
[No Abstract] [Full Text] [Related]
6. Macrophage requirement for production of guinea pig migration inhibitory factor (MIF) in vitro.
Nelson RD; Leu RW
J Immunol; 1975 Feb; 114(2 Pt 1):606-9. PubMed ID: 47355
[TBL] [Abstract][Full Text] [Related]
7. The production by antigen-stimulated lymphocytes of a leukotactic factor distinct from migration inhibitory factor.
Ward PA; Remold HG; David JR
Cell Immunol; 1970 Jul; 1(2):162-74. PubMed ID: 4108781
[No Abstract] [Full Text] [Related]
8. Lymphokine activity in vivo in relation to circulating monocyte levels and delayed skin reactivity.
Yoshida T; Cohen S
J Immunol; 1974 Apr; 112(4):1540-7. PubMed ID: 4131167
[No Abstract] [Full Text] [Related]
9. Macrophage migration from an agarose droplet: development of a micromethod for assay of delayed hypersensitivity.
Harrington JT; Stastny P
J Immunol; 1973 Mar; 110(3):752-9. PubMed ID: 4120226
[No Abstract] [Full Text] [Related]
10. Studies on human migration inhibitory factor: characterization of three molecular species.
Weiser WY; Greineder DK; Remold HG; David JR
J Immunol; 1981 May; 126(5):1958-62. PubMed ID: 7012240
[TBL] [Abstract][Full Text] [Related]
11. Characterization of human migration inhibitory factor (MIF) from antigen-stimulated lymphocytes.
Rocklin RE; Remold HG; David JR
Cell Immunol; 1972 Nov; 5(3):436-45. PubMed ID: 4674910
[No Abstract] [Full Text] [Related]
12. Purification and characterization of lymphocyte mediators in cellular immunity: comparative studies on migration inhibitory factor (MIF) chemotactic factor for macrophages and lymphotoxin.
Remold HG
Transplant Rev; 1972; 10():152-76. PubMed ID: 4342436
[No Abstract] [Full Text] [Related]
13. The allogeneic effect: increased cellular immune and inflammatory responses.
Elfenbein GJ; Green I; Paul WE
J Immunol; 1974 Jun; 112(6):2166-75. PubMed ID: 4133079
[No Abstract] [Full Text] [Related]
14. The mechanism of action of soluble lymphocytic mediators. I. A pulse exposure test for the measurement of macrophage migration inhibitory factor.
Manheimer S; Pick E
Immunology; 1973 Jun; 24(6):1027-34. PubMed ID: 4736924
[TBL] [Abstract][Full Text] [Related]
15. Characterization of migration inhibitory factor (MIF) and its separation from a chemotactic factor for monocytes.
Remold HG; Ward P; David JR
Int Arch Allergy Appl Immunol; 1971; 41(1):16-7. PubMed ID: 5560974
[No Abstract] [Full Text] [Related]
16. Mediators produced by sensitized lymphocytes.
David JR
Fed Proc; 1971; 30(6):1730-5. PubMed ID: 5124960
[No Abstract] [Full Text] [Related]
17. Macrophage receptors for migration inhibitory factor (MIF), migration stimulatory factor (MSF), and agglutinating factor.
Fox RA; Gregory DS; Feldman JD
J Immunol; 1974 May; 112(5):1867-72. PubMed ID: 4594418
[No Abstract] [Full Text] [Related]
18. The enhancement of MIF activity by inhibition of macrophage associated esterases.
Remold HG
J Immunol; 1974 Apr; 112(4):1571-7. PubMed ID: 4592606
[No Abstract] [Full Text] [Related]
19. Lymphocyte-derived eosinophil chemotactic factor. II. Studies on the mechanism of activation of the precursor substance by immune complexes.
Torisu M; Yoshida T; Ward PA; Cohen S
J Immunol; 1973 Nov; 111(5):1450-8. PubMed ID: 4126774
[No Abstract] [Full Text] [Related]
20. Activity of migration inhibitory factor in the absence of antigen.
Yoshida T; Janeway CA; Paul WE
J Immunol; 1972 Aug; 109(2):201-6. PubMed ID: 4114823
[No Abstract] [Full Text] [Related]
[Next] [New Search]
